Trials / Completed
CompletedNCT03270150
Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen
Evaluation of Safety and Efficacy of the BTL-899 Device for Non-invasive Lipolysis and Circumference Reduction of Abdomen
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- BTL Industries Ltd. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
The study is a prospective open-label single-arm study that includes three treatment procedures and four follow-up visits.
Detailed description
This study will evaluate the clinical efficacy and safety of the BTL-899 device for non-invasive lipolysis and circumference reduction of abdomen. The study is a prospective open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will complete three (3) treatment visits and will be invited to four (4) follow-up visits 1, 2, 3 and 6-months after the final treatment. 6-months follow-up visit is the optional one.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BTL-899 | BTL-899 |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2018-09-19
- Completion
- 2018-10-03
- First posted
- 2017-09-01
- Last updated
- 2023-04-12
Locations
1 site across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT03270150. Inclusion in this directory is not an endorsement.